Medical Nutrition Guide: 16 Foods That Support Healthy Weight Loss in Obesity Medical nutrition uses specific whole foods to support steady weight loss in obesity by improving fullness, blood sugar control, and long-term eating habits. Key Takeaways Weight loss in obesity works...

Discover 16 science-backed foods that support healthy weight loss in obesity. Learn how medical nutrition therapy (MNT) uses high-fiber and lean protein to boost satiety.
www.linkedin.com/pulse/medica...

#MedicalNutrition #ObesityManagement

House approves resolution directing PEHP to pilot GLP‑1 coverage and weight‑management program The House passed HCR 8 directing the Public Employees Health Program (PEHP) to establish a pilot weight-management program for qualified public employees that can subsidize GLP‑1 drugs and allow a surgical pathway after six months if drugs are ineffective; the resolution passed 68–2.

Utah's House just approved a groundbreaking resolution to help public employees tackle obesity with subsidized GLP-1 medications and a pathway to bariatric surgery if needed!

Click to read more!

#UT #WellnessAccess #CitizenPortal #HealthInnovation #ObesityManagement

✨ Abstract Submissions Are Now Open!
Join us at the 15th Global Summit on Diabetes & Endocrine Disorders (2026)
🗓️ July 22–23, 2026 |
📍 Tokyo, Japan
🔗 Submit your abstract: diabetes.inovineconferences.com/submit-abstr...

#bariatricsurgery
#metabolicsurgery
#obesitymanagement
#diabetes

Sleeve vs Bypass: How Doctors Decide

Bariatric surgery is never one-size-fits-all. Sleeve gastrectomy and gastric bypass serve different needs based on individual health profiles.

#WeightLossJourney #PersonalisedBariatricCare #ObesityManagement #HealthyWeightLoss

Challenge Yourself: Obesity management after NSTEMI with Drs. Kushner & Michos. Refine your CV risk reduction plan.

👉 Start here: https://ow.ly/pmtj50XH9ht

#PreventiveCardiology #HeartHealth #ObesityManagement #ASPC

How can movement be effectively integrated into #ObesityTreatment — particularly in light of new #GLP1 medications and other shifts in the #ObesityManagement landscape?

Explore the role of #PhysicalActivity in obesity treatment from our new publication: https://ow.ly/RkVQ50XxNk1

Day 2 at the #PCDOConference

Join Dimitris Papamargaritis for 'Masterclass 1: Implementation of Obesity Guidelines' at 11:20.

Don't forget to visit the exhibition space to meet LDC representatives & learn more about our education programmes.

#DiabetesCare #ObesityManagement

Hernia surgery combined with weight loss at Sahaj Hospital in Indore addresses obesity-related hernias with bariatric collaboration reducing recurrence risks through BMI optimization.
📍 Sahaj Hospital, Indore
📞 6262506050

#HerniaSurgery #SahajHospitalIndore #ObesityManagement #WeightLossSurgery

Talking GLP-1s: how GPs see their role in obesity management - BJGP Interviews

Listen to the audio interview with Sabrina Keating and Dr Jadine Scragg on #ObesityManagement with GLP-1RAs bjgplife.com/215 
#Obesity #GLP-1 #PrimaryCare #Prescribing #GeneralPractice #FamilyMedicine

youtu.be/7Y0NE1KKW1U 
Obesity management with GLP-1RAs: this study provides new insights into GPs’ perspectives on the integration of GLP-1RAs into #PrimaryCare doi.org/10.3399/BJGP... #Obesity #ObesityManagement #GLP-1 #Prescribing #GeneralPractice #FamilyMedicine

High dose of Wegovy drives weight loss to 19% A triple dose of Novo Nordisk's GLP-1 agonist Wegovy has shown improved activity on weight loss in an obesity trial versus the current formulation

#obesitymanagement #weighloss #obesity #Wegovy #ObesityActionCoalition #NovoNordisk #GLP1agonist #weightloss #obesitytrial #EliLilly #Lilly #TheLancetDiabetesandEndocrinology #STEPUPT2D #highdosesemaglutide #dualGIPGLP1agonist #Zepbound #tirzepatide #oralGLP1agonist
zurl.co/GCtWR

Pet Obesity Management Market Size, Growth, Report 2035 Pet Obesity Management Market growth is projected to reach USD 2.12 Billion, at a 7.80% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 t...

🐶🐱💊
Chubby pets are on the rise, but so are solutions! 🩺 With growing awareness in pet health & wellness, this market is booming. 🐾 #PetCare #ObesityManagement #VetHealth

www.marketresearchfuture.com/reports/pet-...

▶️ Listen here as Dr. Louis Aronne discusses the difference between #semaglutide and #tirzepatide.

Find the full #CME podcast episode, featuring host Dr. Robert Kushner, at this link: www.healio.com/cme/mededtal...

#obesitymanagement #obesitycare

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations - Drugs in Context This narrative review provides a comprehensive examination of the current landscape of GCGR-based combinations in phase III trials for the treatment of obesity.

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations

Sarah L. Anderson

@drugsincontext.bsky.social #MedSky #PharmSky #GLP1 #GLP1RA #obesity #obesitymanagement #pharmacology #clinicaltrials

www.drugsincontext.com/emerging-con...

A new approach to obesity management Northern Ireland has announced the country’s first obesity management service. Its phased and cautious approach chimes with a new report from the Tony Blair Institute for Global Change.

Northern Ireland has announced the country’s first obesity management service. Its phased and cautious approach chimes with a new report from the Tony Blair Institute for Global Change.

healthcaretoday.com/article/a-ne...

#healthcare #publichealth #obesitymanagement #patientsafety

Intragastric Balloon Market Size, Trends, Report 2035 | MRFR Intragastric Balloon Market 2025, Industry to reach 3.5 USD billion, at a 4.24% CAGR by growing size, share, top company analysis, segments research, trends and forecast to 2035.

Shaping the future of weight loss! 🎈💪 #IntragastricBalloon offers a non-surgical path to healthier living.
#WeightLossSolutions #BariatricCare #ObesityManagement

www.marketresearchfuture.com/reports/intr...

🚨 Just published! 🚨

📢 New State-of-the-Art Review: A cardiologist’s guide to the latest advances in obesity management in cardiovascular care. 💙🫀

🔗 Read more: ow.ly/gqxV50VuJ0p

#CardioSky #MedSky #Cardiology #ObesityManagement #HeartHealth #MedicalResearch

North Dakota Assembly introduces antiobesity medication coverage bill Representatives Nelson and Mitskog propose legislation for health insurance antiobesity medication coverage

North Dakota is on the verge of a healthcare revolution as lawmakers propose a bill to mandate insurance coverage for antiobesity medications—could this be the game-changer in the fight against obesity?

Click to read more!

#ND #ObesityManagement #CitizenPortal #PublicHealthOutcomes

Once monthly injectables to become future therapeutic options for obesity: Report - Yes Punjab News "New report predicts next-gen obesity management drugs, including once-monthly injectable GLP-1R agonists by Amgen and Metsera, may revolutionize treatment and impact global obesity rates."

Once monthly injectables to become future therapeutic options for obesity: Report
yespunjab.com?p=82040

#ObesityTreatment #MonthlyInjectables #HealthInnovation #ObesityManagement #TherapeuticOptions #WeightLoss #FutureOfMedicine #ObesitySolutions #HealthReport #MedicalAdvancements

Innovative Developments in Pharma and Digital Health: Major Collaborations and Advances in South Korea In a wave of innovation sweeping through the South Korean healthcare sector, several companies and institutions are pushing the boundaries of both pharmaceutical advancements and digital health techno...

www.linkedin.com/pulse/innova...

Innovative Developments in Pharma and Digital Health: Major Collaborations and Advances in South Korea

kstrategyand.com

#HealthcareInnovation #ObesityManagement #CancerResearch #SouthKorea #CancerTreatment #LongActingInjections #Humanteconomy #Humantec

The image shows the packaging for Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, designed for once-weekly subcutaneous use. The box highlights that it contains four single-dose prefilled pens, each delivering a dose of 2.4 mg semaglutide. The pens are shown alongside the packaging, and the product is manufactured by Novo Nordisk.

EU regulators recommend updating Wegovy's label to include heart failure in obesity management. This marks a key step in recognizing obesity as a major factor in heart health.

jcst2d.com/index.php?vi...

#ObesityManagement #HeartHealth #Wegovy #EU #MedicalNews